● Recruiting

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Condition: Endometrial Neoplasms · Atypical Endometrial Hyperplasia · Progesterone Resistance · Sponsor: Xiaojun Chen

PhasePhase 2/Phase 3

Planned participants80

Who can joinFemale, 18 Years to 45 Years

Healthy volunteersNo

About this study

To investigate the efficacy of GnRHa plus letrozole vs Diane-35 plus metformin in non-obese progestin-insensitive early-stage endometrial cancer (EEC) and atypical hyperplasia(EAH) patients asking for conservative treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaojun Chen, PhD · 8602133189900 · cxjlhjj@163.com

Bingyi Yang · 8602133189900 · xiaomihaoku@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

Obstetrics and Gynecology Hospital, Fudan University	Shanghai, Shanghai Municipality, China	Recruiting
Tenth People's Hospital of Tongji University	Shanghai, Shanghai Municipality, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05316935